Grant: Operating Grant: Women's Health Clinical Mentorship Grant
University of British Columbia
$50,000.00
Preventing unnecessary surgeries for endometriosis with the Central Sensitization Inventory
EF 2019-20
Résumé
Endometriosis affects 1 in 10 reproductive-aged women, or approximately 1 million women in Canada. It is defined as tissue from inside the uterus (womb), being able to grow as implants outside of the uterus, in other parts of the body. Endometriosis is a common cause of infertility and pelvic pain, including painful periods, painful sexual activity, and chronic pelvic pain. Treatment consists of hormonal medications or surgical removal of the implants.
Historically, the endometriosis implants themselves were thought to be the primary cause of pain. However, recent research as shown that in many patients with endometriosis, the primary cause of pain consists of changes in the central nervous system (brain and spinal cord) -- known as central sensitization -- rather than the endometriosis implants themselves. In these patients with central sensitization, repeated surgery to try to remove endometriosis implants is unlikely to be helpful.
The problem is that research methodologies to measure central sensitization are not practicable for the clinical setting. There is a need for a clinical tool that can easily identify central sensitization, thereby helping clinicians and patients to determine when surgery is not likely to be helpful. Recently, the Central Sensitization Inventory (CSI) -- a patient-reported questionnaire -- has been shown to be validly identify patients with central sensitization.
In this proposal, we will use the CSI in an ongoing prospective registry for endometriosis. We will determine whether the CSI can predict whether endometriosis surgery is effective or not. A cut-off for the CSI score will be identified, which can be used by clinicians and patients in their shared decision making about whether to proceed with surgery.
The goal will be to reduce unnecessary repeat surgeries for endometriosis in women. This will be achieved by promoting the CSI in the national clinical practice guidelines for endometriosis and for pelvic pain.
Programme
Operating Grant: Women's Health Clinical Mentorship Grant
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
415567
Name
Yong Paul
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Women's Health Clinical Mentorship Grant
Projecttitle
Preventing unnecessary surgeries for endometriosis with the Central Sensitization Inventory
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Operating Grant: Women's Health Clinical Mentorship Grant
Keyworddelim
Central Sensitization; Dysmenorrhea; Dyspareunia; Endometriosis; Pelvic Pain
Abstract
Endometriosis affects 1 in 10 reproductive-aged women, or approximately 1 million women in Canada. It is defined as tissue from inside the uterus (womb), being able to grow as implants outside of the uterus, in other parts of the body. Endometriosis is a common cause of infertility and pelvic pain, including painful periods, painful sexual activity, and chronic pelvic pain. Treatment consists of hormonal medications or surgical removal of the implants.
Historically, the endometriosis implants themselves were thought to be the primary cause of pain. However, recent research as shown that in many patients with endometriosis, the primary cause of pain consists of changes in the central nervous system (brain and spinal cord) -- known as central sensitization -- rather than the endometriosis implants themselves. In these patients with central sensitization, repeated surgery to try to remove endometriosis implants is unlikely to be helpful.
The problem is that research methodologies to measure central sensitization are not practicable for the clinical setting. There is a need for a clinical tool that can easily identify central sensitization, thereby helping clinicians and patients to determine when surgery is not likely to be helpful. Recently, the Central Sensitization Inventory (CSI) -- a patient-reported questionnaire -- has been shown to be validly identify patients with central sensitization.
In this proposal, we will use the CSI in an ongoing prospective registry for endometriosis. We will determine whether the CSI can predict whether endometriosis surgery is effective or not. A cut-off for the CSI score will be identified, which can be used by clinicians and patients in their shared decision making about whether to proceed with surgery.
The goal will be to reduce unnecessary repeat surgeries for endometriosis in women. This will be achieved by promoting the CSI in the national clinical practice guidelines for endometriosis and for pelvic pain.
Competitiondate
201910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yong, Paul
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~